Additionally, GSK3B-KO NK cells showed similar killing potency as WT NK cell against HL60 (AML), K562 (CML), DAOY (medulloblastoma), and MG63 (osteosarcoma) in a standard 4 h killing assay (see supplementary Figure S3). Here, GSK3B is linked to chronic myelogenous leukemia, BCR-ABL1 positive.